Tamiflu May Be Linked to Risk for Self-Injury and Delirium
Wednesday, November 15th 2006
November 14, 2006 -- The US Food and Drug Administration (FDA) and Roche Laboratories Inc have notified healthcare professionals regarding safety labeling revisions for oseltamivir phosphate (Tamiflu capsules and suspension) that warn of the potential risk for neuropsychiatric events associated with its use.
The warning was based on postmarketing reports (primarily from Japan) suggesting that patients with influenza receiving oseltamivir, particularly children, may be at increased risk for self-injury and delirium.
Although the role of the drug remains unclear, patients receiving oseltamivir should be closely monitored for signs of abnormal behavior, according to an alert sent yesterday from MedWatch, the FDA's safety information and adverse event reporting program.
Oseltamivir is indicated for the prophylaxis of influenza and treatment of uncomplicated acute illness in those who have been symptomatic for no longer than 2 days. It is approved for use in patients aged 1 year and older.
Sourced from the Medscape website, Yael Waknine, Nov 14, 2006. Article 547783.
Footnote from Ideal Health:
The following products are all useful for Supporting Immune Function:
Immune Booster for Kids
Immune Defence Cough Cold Relief
Kids Defence Herbal Drops
Ester C 1000mg + Bioflavonoids
Olive Leaf Complex
Vitamin C with Hesperidin Complex
Related health information can be found here:
Related articles can be found here:
Dangers of prescription drugs
Childhood Vaccination: Is There a "dark side"
Drug-pumped poultry fuels human risk
Iron Supplementation Beneficial in Healthy, Full-Term Infants
Medical mishaps strike one in ten
Smallpox Vaccine-Related Myopericarditis and Encephalomyelitis Cases Under Investigation
If you need help or advice, you are welcome to email our naturopathic team with your health question.
Disclaimer: The health information presented here has been written for the New Zealand health consumer. It is of a general nature and is only intended to provide a summary of the subjects covered. The information is not intended to be comprehensive or to provide medical advice to you. While all care has been taken to ensure the accuracy of the information, no responsibility or liability is accepted, and no person should act in reliance on any statement contained in the information provided. All health ailments should be treated by a qualified health professional.
Previous news itemRespiratory Symptoms Strongly Predict More Persistent Cow's Milk Allergy
15 Nov 2006
Next news itemHot Air May Be an Effective Nonchemical Treatment of Head Lice
15 Nov 2006